Maria Del Pilar Woods, FNP | |
673 Mdg, 5955 Zeamer Ave, Jber, AK 99506 | |
(907) 580-8303 | |
Not Available |
Full Name | Maria Del Pilar Woods |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 673 Mdg, Jber, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497427363 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 1051783 (Texas) | Secondary |
363LF0000X | Nurse Practitioner - Family | A172986 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maria Del Pilar Woods, FNP 673 Mdg, 5955 Zeamer Ave, Jber, AK 99506 Ph: (907) 580-8303 | Maria Del Pilar Woods, FNP 673 Mdg, 5955 Zeamer Ave, Jber, AK 99506 Ph: (907) 580-8303 |
News Archive
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
Genesis HealthCare, one of the nation's largest providers of skilled nursing and rehabilitation, today announced that three of its Centers have been recognized as recipients of the Silver – Achievement in Quality Award presented by the American Health Care Association and the National Center for Assisted Living.
A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Ambrx today announced that the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East respiratory syndrome (MERS) found that they were well tolerated and generally safe when administered simultaneously to healthy adults.
› Verified 7 days ago
Christina Colica, MSN, APRN,WHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 171a Sparta Way Unit A, Jber, AK 99505 Phone: 954-661-6855 | |
Mrs. Melanie Ann Fry, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 673 Mdg, 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2908 Fax: 575-356-5948 | |
Mrs. Mary Theresa Floyd, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8497 Reckenbacker, Jber, AK 99506 Phone: 907-551-4015 | |
Casey Granger, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8415 Metzger Ave Unit A, Jber, AK 99506 Phone: 402-926-8352 | |
Ms. Cecelia P Maher, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 724 Postal Service Loop, Box 7499, Jber, AK 99505 Phone: 907-384-0830 | |
Mr. Geoffrey John Mittelsteadt, ACUTE CARE NURSE PRA Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-8084 | |
Ms. Kathryn R Zarobsky, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5955 Zeamer Ave, 673d Mdg, Jber, AK 99506 Phone: 907-580-2908 |